Evidence map›Paper›PMID 28380628›Full record

ArticleHealth education research2017

Physicians' perspectives on the informational needs of low-risk prostate cancer patients.

Charlotte J Hagerman, Paula G Bellini, Kim M Davis, Richard M Hoffman, David S Aaronson, Daniel Y Leigh, Riley E Zinar, David Penson, Stephen Van Den Eeden, Kathryn L Taylor

Abstract read
In one paragraph

Article in Health education research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Exploring the impact of providing men with information about potential prostate cancer treatment options prior to receiving biopsy results.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Charlotte J HagermanDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
Paula G BelliniDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
Kim M DavisDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
Richard M HoffmanDivision of General Internal Medicine, University of Iowa Carver College of Medicine/Iowa City VA Medical Center, Iowa City, IA 52242, USA.
David S AaronsonDepartment of Urology, Kaiser Permanente, East Bay, Oakland, CA 94611, USA.
Daniel Y LeighDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
Riley E ZinarDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.
David PensonDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA.
Stephen Van Den EedenDivision of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA.
Kathryn L TaylorDepartment of Oncology, Georgetown University Medical Center, Lombardi Comprehensive Cancer Center, Washington DC 20007, USA.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
TREATMENT DECISIONS AND PATIENT REPORTED OUTCOMES IN LOW RISK PROSTATE CANCERR01CA155578 · NCI · GEORGETOWN UNIVERSITY · PI TAYLOR, KATHRYN L, VAN DEN EEDEN, STEPHEN K. · 2011 to 2015
$3.1M
NCI NIH HHS R01 CA155578
6 · The paper itself

Abstract

Despite the evidence indicating that decision aids (DA) improve informed treatment decision making for prostate cancer (PCa), physicians do not routinely recommend DAs to their patients. We conducted semi-structured interviews with urologists (n = 11), radiation oncologists (n = 12) and primary care physicians (n = 10) about their methods of educating low-risk PCa patients regarding the treatment decision, their concerns about recommending DAs, and the essential content and format considerations that need to be addressed. Physicians stressed the need for providing comprehensive patient education before the treatment decision is made and expressed concern about the current unevaluated information available on the Internet. They made recommendations for a DA that is brief, applicable to diverse populations, and that fully discloses all treatment options (including active surveillance) and their potential side effects. Echoing previous studies showing that low-risk PCa patients are making rapid and potentially uninformed treatment decisions, these results highlight the importance of providing patient education early in the decision-making process. This need may be fulfilled by a treatment DA, should physicians systematically recommend DAs to their patients. Physicians' recommendations for the inclusion of particular content and presentation methods will be important for designing a high quality DA that will be used in clinical practice.

Indexed as

Decision MakingDecision Support TechniquesHumansInformation Seeking BehaviorInternetInterviews as TopicMalePatient Education as TopicPhysiciansProstatic NeoplasmsRadiation OncologyUrology

Identifiers

PMID28380628
PMCPMC5914350

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.